Sun Pharma Advanced Research reports net loss of Rs 61 crore in Q1

Sun Pharma Advanced Research Company Ltd. | Business Support | Miscellaneous | BSE: 532872 | NSE: SPARC

27 Jul 2021 Evaluate

Sun Pharma Advanced Research (SPARC) has reported results for first quarter ended June 30, 2021.

The company has reported net loss at Rs 61.37 crore for the quarter under review as compared to net profit of Rs 56.69 crore for the same quarter in the previous year. Total income of the company decreased by 87.75% at Rs 22.79 crore for Q1FY22 as compared Rs 186.11 crore for the corresponding quarter previous year.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Peers

Company Name	CMP
Sagility	45.94
Prime Focus	352.35
Knowledge RealtyTrt.	113.71
Indegene	596.10
Syngene Internatl.	385.35
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.